What is the survival rate for stage 3A endometrial serous carcinoma with cancer cells in pelvic washings after hysterectomy, chemotherapy with carboplatin and paclitaxel, and 2 years of Kanjinti?
Stage 3 endometrial cancer has a five-year relative survival rate of 70 percent. This means you're 70 percent as likely to be Show Full Answer
What is the survival rate for stage 3A endometrial serous carcinoma with cancer cells in pelvic washings after hysterectomy, chemotherapy with carboplatin and paclitaxel, and 2 years of Kanjinti?
Stage 3 endometrial cancer has a five-year relative survival rate of 70 percent. This means you're 70 percent as likely to be alive after five years compared to someone without endometrial cancer.
However, serous endometrial carcinoma is more aggressive. For stage 3 or 4 serous endometrial cancer specifically, the five-year survival rate is around 33 percent.
Your treatment plan sounds comprehensive. The combination of surgery, chemotherapy with carboplatin and paclitaxel, and targeted therapy like Kanjinti represents standard and advanced care for stage 3 endometrial cancer.
Keep in mind that survival rates are estimates based on large groups of people. Your individual outlook depends on several factors:
* How well you respond to treatment
* Your overall health
* Your age
* Other health conditions you may have
Advances in cancer research continue to develop new treatments that may provide better outcomes than older statistics show. Talk with your cancer care team to get a more personalized understanding of your prognosis based on your specific situation and treatment response.
March 27
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
